(MXF.L) Medicx Fund Ltd Buy/Sell

RNS Number : 3552C The MedicX Fund Limited 11 November 2009

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are Medicx Fund Ltd

attached: ii 2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify):
3. Full name of person(s) subject to the Rensburg Sheppards Investment Management Limited

notification obligation: iii
4. Full name of shareholder(s) N/A

(if different from 3.):iv
5. Date of the transaction and date on 10th November 2009

which the threshold is crossed or reached: v
6. Date on which issuer notified: 11th November 2009
7. Threshold(s) that is/are crossed or 19%

reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction

if possible using the ISIN CODE
Number Number Number Number of voting % of voting rights x
of of of shares rights
Shares Voting
Rights
Direct Direct xi Indirect xii Direct Indirect
Ordinary Shares 18,469,323 18,469,323 19,957,951 19.00%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction
Type of financial Exercise price Expiration date xvii Exercise/ Number of voting rights instrument refers to % of voting rights xix, xx
instrument Conversion period xviii
Nominal Delta

Total (A+B+C)
Number of voting rights Percentage of voting rights
19,957,951 19.00%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi Client holdings registered in the name of Nominee companies 100% owned by Rensburg Sheppards Investment Management Limited.

Proxy Voting: 10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold: N/A

12. Date on which proxy holder will cease to hold
voting rights: N/A

13. Additional information:

14. Contact name:

15. Contact telephone number:

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name Rensburg Sheppards
(including legal form of legal entities) Investment
Management Limited
Contact address Quayside House
(registered office for legal entities) Canal Wharf
Leeds LS11 5PU
Phone number & email 0113 236 4171
mike.rigby@rsim.co.
uk
Other useful information Mike Rigby
(at least legal representative for legal persons) (Head of Compliance)

B: Identity of the notifier, if applicable
Full name Philip Martin
Beardwell
Contact address 2 Gresham Street
London

Phone number & email 020 7597 1356
phil.beardwell@rsim.
co.uk
Other useful information Senior Compliance
(e.g. functional relationship with the person or legal entity subject to the notification Manager

obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS The company news service from the London Stock Exchange

HOLEALFFFEDNFFE

RNS Number : 4166A The MedicX Fund Limited 07 October 2009

For Immediate Release 7 October 2009

MedicX Fund Limited

Issue of new ordinary shares

MedicX Fund Limited (the "Company") announces that earlier today it issued for cash 500,000 new ordinary shares of no par value in the Company (the "New Shares"). The issue price per New Share (before expenses) is 72.5 pence.

The net proceeds will be used in further pursuing the investment objectives of the Company.

The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.

Following this issue, the Company has 105,021,215 ordinary shares in issue.

For further information, please contact:

MedicX Fund Limited

David Staples, Chairman +44 (0)1481 723 450

MedicX Group

Keith Maddin, Chairman

Mike Adams, Managing Director +44 (0)808 2025461

Buchanan Communications

Charles Ryland/Miranda Higham/Mary-Jane Johnson +44(0)20 7466 5000

Collins Stewart Europe Limited

Andrew Zychowski/Robbie Robertson +44 (0)20 7523 8000

Collins Stewart Europe Limited, which is authorised and regulated by the Financial Services Authority, is acting for MedicX Fund Limited and for no one else in connection with the matters detailed in this announcement and will not be responsible to anyone other than MedicX Fund Limited for providing the protections afforded to clients of Collins Stewart Europe Limited or for affording advice in relation hereto, or any other matters referred to herein.

This information is provided by RNS The company news service from the London Stock Exchange

IOEMGMGGKNDGLZM

RNS Number : 1891A The MedicX Fund Limited 05 October 2009

For immediate release 5 October 2009

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Acquisition of three primary care centres

MedicX Fund Limited, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built,

primary healthcare properties in the United Kingdom, today announces that it has entered into a forward funding agreement to acquire three primary care centres at Ruabon (North Wales), Scholar Green (Staffordshire) and Middlewich (Cheshire). Expected completion dates are mid 2010 for Ruabon and late 2010 for Scholar Green and Middlewich.

The total acquisition cost of the three properties is anticipated to be £13.89 million and they have been valued by King Sturge LLP, valuers for the MedicX Fund, at £13.43 million after allowing for purchasers costs of £770,000.

The properties will be fully let to GP, PCT and pharmacy tenants for initial terms of 20 years (21 years at Middlewich) with an aggregate net rent of £882,516 per annum. All leases provide for three-yearly rent reviews, the majority of the income being reviewed to open market value (£120,000 of the income is subject to three-yearly RPI increases).

The total property portfolio owned by the MedicX Fund now comprises 50 properties throughout the United

Kingdom of which three are under construction with a further two due to commence on site late 2009/early 2010. The annualised rent roll for all properties is now £11.7 million.

End

For further information please contact:

MedicX Fund +44 (0) 1481 723 450

David Staples, Chairman

MedicX Group +44 (0) 808 202 5461

Keith Maddin, Chairman

Mike Adams, Managing Director

Buchanan Communications +44 (0) 20 7466 5000

Charles Ryland / Miranda Higham

This information is provided by RNS The company news service from the London Stock Exchange

ACQMTBFTMMMMBRL

RNS Number : 1058Z The MedicX Fund Limited 15 September 2009

Financial Services Authority

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer MedicX Fund Ltd

of existing shares to which voting rights are attached:

2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights Yes

Other (please specify):

3. Full name of person(s) subject to the Legal & General Group Plc (Group)

notification obligation:

Legal & General Investment Management Limited

4. Full name of shareholder(s) N/A

(if different from 3.):
11 September 2009

5. Date of the transaction and date on which the threshold is crossed or reached:

6. Date on which issuer notified: 15 September 2009
7. Threshold(s) that is/are crossed or Below 5% (Group)

reached:

Below 5% (LGIM)

8. Notified details:

A: Voting rights attached to shares
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction

if possible using the ISIN CODE
Number Number Number of voting % of voting rights
of of Number rights
Shares Voting of shares
Rights
Direct Indirect Direct Indirect
ORD 5,181,209 5,181,209 Below 5%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction
Number of voting
Type of financial Expiration Exercise/ rights that may be % of voting
instrument date Conversion Period acquired if the rights
instrument is
exercised/ converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Resulting situation after the triggering transaction

Type of financial Exercise price Expiration date Exercise/ Number of voting rights instrument refers to % of voting rights
instrument Conversion period
Nominal Delta

Total (A+B+C)
Number of voting rights Percentage of voting rights
Below 5%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Legal & General Group Plc (Direct and Indirect) (Group) (Below 5% = Total Position) Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) (Below 5% = Total Position) Legal & General Investment Management Limited (Indirect) (LGIM) (Below 5% = Total Position)
Legal & General Group Plc (Direct) (L&G)
Legal & General Investment Legal & General Insurance Holdings Limited

Management (Holdings) Limited (Direct) (LGIH) (Direct) (LGIMHD)
Legal & General Assurance Legal & General Assurance Society Limited
(Pensions Management) Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct)

Proxy Voting:
10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease

to hold:

12. Date on which proxy holder will cease to hold

voting rights:

13. Additional information:
Notification using the total voting rights figure of 104,521,215
14. Contact name:
Helen Lewis (LGIM)
15. Contact telephone number:

This information is provided by RNS The company news service from the London Stock Exchange

HOLEALNSFLKNEFE